You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 00378-0127


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00378-0127

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 00378-0127

Understanding the NDC Code

To begin analyzing the market and price projections for the drug with the NDC code 00378-0127, it is crucial to understand what the NDC code represents. The National Drug Code (NDC) is a unique 10-digit, three-segment number that identifies the labeler, product, and package size of a drug product[5].

  • Labeler Code: The first segment (00378) is assigned by the FDA and identifies the labeler, which could be a manufacturer, repackager, or relabeler.
  • Product Code: The second segment (012) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment (7) identifies the package size and type.

Market Context

Pharmaceutical Industry Trends

The pharmaceutical industry is undergoing significant transformations driven by trends such as prevention, personalization, prediction, and point of care. These trends are shifting the focus towards data-driven, customized treatments and early intervention to improve health outcomes[3].

Competition and Generic Drug Prices

For drugs that have generic versions, the market is generally competitive, leading to substantial price reductions. When a generic drug enters the market, prices typically fall as the number of competitors increases. For example, in markets with 10 or more generic competitors, prices can decline by up to 80% relative to the pre-generic entry brand price[4].

Price Transparency and Regulation

Drug Price Transparency Programs

Programs like Oregon's Drug Price Transparency Program highlight the variability in drug pricing and the need for transparency. These programs reveal significant price increases, such as the 2,527% increase for a generic naproxen, and emphasize the gaps in transparency across the pharmaceutical supply chain[2].

Regulatory Oversight

The FDA's National Drug Code Directory contains information on active and certified finished and unfinished drugs, including those with NDC codes like 00378-0127. However, the assignment of an NDC number does not denote FDA approval, and it is important to distinguish between NDC listing and regulatory approval[1][5].

Price Projections

Impact of Competition

If the drug with NDC 00378-0127 has a generic version, the price is likely to decrease as more competitors enter the market. For instance, in the first 24-36 months after generic entry, prices can decline by 20% relative to the brand drug price in markets with three generic competitors[4].

Historical Price Trends

Analyzing historical data on similar drugs can provide insights into potential price trends. For example, the median price increase for generic drugs was 19.9% in 2022, while brand name drugs saw a median increase of 13.4%[2].

Market Analysis

Market Size and Competitiveness

The competitiveness of the market for the drug with NDC 00378-0127 depends on the number of suppliers and the market size. Larger markets with more competitors tend to have larger incremental price reductions compared to smaller markets[4].

Supply Chain Transparency

Understanding the various cost factors in the pharmaceutical supply chain, such as coupons, discounts, fees, and rebates, is crucial for accurate price projections. Transparency across the supply chain can help in identifying what influences and contributes to the final cost of the drug to consumers[2].

Expert Insights

"The quality of information submitted by manufacturers was extremely variable, ranging from refusals to provide any information to generalized descriptions to detailed information of a company’s reasons for increasing the price of a drug."

  • Oregon's Drug Price Transparency Program Report[2]

This variability highlights the challenges in predicting drug prices accurately without comprehensive data.

Illustrative Statistics

  • Generic Drug Price Reductions: In markets with 10 or more generic competitors, prices can decline by up to 80% relative to the pre-generic entry brand price[4].
  • Price Increases: The largest price increase reported in 2022 was a 2,527% increase for a generic naproxen, from $34.13 in 2012 to $896.44 in 2021[2].

Key Takeaways

  • NDC Code Significance: The NDC code is essential for identifying the drug product, but it does not indicate FDA approval.
  • Market Competition: The presence of generic competitors significantly reduces drug prices.
  • Regulatory Transparency: Programs like Oregon's Drug Price Transparency Program are crucial for understanding price trends and gaps in transparency.
  • Supply Chain Factors: Various cost factors in the pharmaceutical supply chain influence the final cost of drugs to consumers.

FAQs

1. What does the NDC code 00378-0127 represent? The NDC code 00378-0127 is a unique identifier for a drug product, consisting of a labeler code, product code, and package code.

2. How does competition affect drug prices? Competition, especially from generic drugs, significantly reduces prices. In markets with multiple generic competitors, prices can decline by up to 80% relative to the pre-generic entry brand price.

3. What is the significance of drug price transparency programs? These programs provide accountability for prescription drug pricing, revealing price trends and gaps in transparency across the pharmaceutical supply chain.

4. Does the NDC Directory indicate FDA approval? No, the assignment of an NDC number does not denote FDA approval of the product.

5. How do supply chain factors influence drug prices? Factors such as coupons, discounts, fees, and rebates in the pharmaceutical supply chain can significantly influence the final cost of drugs to consumers.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon's Drug Price Transparency Program
  3. Pharma industry trends: PwC
  4. Medicare Part D: Competition and Generic Drug Prices, 2007-2018 - ASPE
  5. NDC Codes - National Drug Codes - Find-A-Code

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.